Further investigations revealed that also in other cancers including lung cancer, pancreatic cancer, and renal cancer, patients with lower levels of MMP24 expression exhibit lower overall survival rates (Figure 5A–C). This evidence concerns the gene MMP24 and renal carcinoma.